Abstract：
Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding. Most data on the safety of these medications are from recreational abuse of methamphetamine. This study followed children (N = 13) exposed to amphetamine stimulants during breastfeeding. Assessments by Pediatric Quality of Life and Denver Developmental Scale evaluated neurodevelopment and outcomes. Study results showed normal neurodevelopment with no significant adverse effects. Findings suggest amphetamines are likely compatible with breastfeeding; however larger studies are needed.
摘要：
注意缺陷多动障碍（ADHD）药物的使用在育龄妇女和怀孕期间上升。对苯丙胺兴奋剂在母乳喂养期间用于ADHD治疗的安全性知之甚少。关于这些药物安全性的大多数数据来自娱乐性滥用甲基苯丙胺。这项研究追踪了母乳喂养期间暴露于苯丙胺兴奋剂的儿童（N=13）。通过儿科生活质量和丹佛发展量表评估神经发育和结果。研究结果表明神经发育正常，无明显不良反应。研究结果表明，苯丙胺可能与母乳喂养兼容；但是需要进行更大的研究。
